Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-61,963
Closed -$16.4M 781
2021
Q1
$16.4M Sell
61,963
-20,678
-25% -$5.83M 0.03% 283
2020
Q4
$24.2M Sell
82,641
-8,368
-9% -$2.15M 0.04% 232
2020
Q3
$21.5M Buy
91,009
+7,759
+9% +$1.76M 0.04% 230
2020
Q2
$16.5M Buy
83,250
+21,979
+36% +$4.1M 0.04% 249
2020
Q1
$11.2M Sell
61,271
-215
-0.3% -$38.3K 0.03% 296
2019
Q4
$10.3M Buy
61,486
+20,524
+50% +$3.05M 0.02% 361
2019
Q3
$5.37M Buy
+40,962
New +$5.33M 0.01% 482
2015
Q2
Sell
-24,670
Closed -$660K 1489
2015
Q1
$660K Sell
24,670
-592
-2% -$16.7K ﹤0.01% 1269
2014
Q4
$741K Sell
25,262
-2,403
-9% -$59.3K ﹤0.01% 1227
2014
Q3
$558K Sell
27,665
-58
-0.2% -$1.12K ﹤0.01% 1323
2014
Q2
$464K Buy
27,723
+156
+0.6% +$2.21K ﹤0.01% 1338
2014
Q1
$411K Sell
27,567
-1,167
-4% -$18K ﹤0.01% 1386
2013
Q4
$421K Sell
28,734
-720
-2% -$11.6K ﹤0.01% 1379
2013
Q3
$507K Sell
29,454
-4,950
-14% -$73.4K ﹤0.01% 1339
2013
Q2
$400K Buy
+34,404
New +$394K ﹤0.01% 1357

Other funds holding AMED

Putnam Investments's AMED Position: Q2 2021 in Review

Putnam Investments sold out of Amedisys (AMED) in Q2 2021, closing a stake of 61,963 shares — an estimated $16.4M sold.

Putnam Investments first reported a position in AMED in Q2 2013 and held it in 15 quarters. The position peaked at $24.2M in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Putnam Investments reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Putnam Investments sold 61,963 Amedisys shares in Q2 2021, an estimated $16.4M.
  • Putnam Investments first reported a position in Amedisys in Q2 2013 and held it in 15 quarters.
  • Putnam Investments's Amedisys position peaked at $24.2M in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Putnam Investments's 13F filing for Q2 2021, filed 16 Aug 2021.